You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ATTO Conversion Disclosure
Sanofi · SEC Form 4 · Filed Aug 7, 2026
Conversion
Reported value range
Not reported
Sanofi 10% owner
ATTO
Transaction date
Aug 6, 2026
Public filing date
Aug 7, 2026
Filing lag
Filed 1 day later
ATTO daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series C Preferred Stock on Common Stock
- Quantity / price
- 782,855 shares
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001193125-26-340173
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$5.1M
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | Not reported |
| Attovia Therapeutics, Inc. ATTO | Buy | Aug 6, 2026 | $5.1M |
| Attovia Therapeutics, Inc. ATTO Current | Conversion | Aug 6, 2026 | Not reported |